APA (7th ed.) Citation

Osataphan, S., Awidi, M., Jan, Y. J., Gunturu, K., Sundararaman, S., Viray, H., . . . Rangachari, D. (2024). Association between higher glucose levels and reduced survival in patients with non-small cell lung cancer treated with immune checkpoint inhibitors. Lung Cancer (01695002), 198, N.PAG. https://doi.org/10.1016/j.lungcan.2024.108023

Chicago Style (17th ed.) Citation

Osataphan, Soravis, et al. "Association Between Higher Glucose Levels and Reduced Survival in Patients with Non-small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors." Lung Cancer (01695002) 198 (2024): N.PAG. https://doi.org/10.1016/j.lungcan.2024.108023.

MLA (9th ed.) Citation

Osataphan, Soravis, et al. "Association Between Higher Glucose Levels and Reduced Survival in Patients with Non-small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors." Lung Cancer (01695002), vol. 198, 2024, p. N.PAG, https://doi.org/10.1016/j.lungcan.2024.108023.